Currie, D.; Wong, N.; Zane, I.; Rix, T.; Vardakastanis, M.; Claxton, A.; Ong, K.K.V.; Macmorland, W.; Poivet, A.; Brooks, A.;
et al. A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients. Cancers 2024, 16, 722.
https://doi.org/10.3390/cancers16040722
AMA Style
Currie D, Wong N, Zane I, Rix T, Vardakastanis M, Claxton A, Ong KKV, Macmorland W, Poivet A, Brooks A,
et al. A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients. Cancers. 2024; 16(4):722.
https://doi.org/10.3390/cancers16040722
Chicago/Turabian Style
Currie, David, Nicole Wong, Isabelle Zane, Tom Rix, Marios Vardakastanis, Amelia Claxton, Karine K. V. Ong, William Macmorland, Arthur Poivet, Anthony Brooks,
and et al. 2024. "A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients" Cancers 16, no. 4: 722.
https://doi.org/10.3390/cancers16040722
APA Style
Currie, D., Wong, N., Zane, I., Rix, T., Vardakastanis, M., Claxton, A., Ong, K. K. V., Macmorland, W., Poivet, A., Brooks, A., Niola, P., Huntley, D., & Montano, X.
(2024). A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients. Cancers, 16(4), 722.
https://doi.org/10.3390/cancers16040722